Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
19.93
+0.57 (2.94%)
At close: May 12, 2025, 4:00 PM
19.78
-0.15 (-0.75%)
After-hours: May 12, 2025, 4:05 PM EDT
Genmab Employees
Genmab had 2,682 employees as of December 31, 2024. The number of employees increased by 478 or 21.69% compared to the previous year.
Employees
2,682
Change (1Y)
478
Growth (1Y)
21.69%
Revenue / Employee
$1,168,955
Profits / Employee
$423,920
Market Cap
12.23B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
GMAB News
- 15 hours ago - Transactions in Connection with Share Buy-back Program - GlobeNewsWire
- 4 days ago - Genmab Announces Financial Results for the First Quarter of 2024 - GlobeNewsWire
- 7 days ago - Transactions in Connection with Share Buy-back Program - GlobeNewsWire
- 11 days ago - Genmab to Submit Supplemental Biologics License Application (sBLA) to U.S. Food and Drug Administration for Epcoritamab Plus Rituximab and Lenalidomide (R2) in Patients with Relapsed/Refractory Follicular Lymphoma (FL) - Business Wire
- 27 days ago - Genmab's Outlook Beyond Darzalex's Patent Cliff - Seeking Alpha
- 27 days ago - Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2025 - GlobeNewsWire
- 4 weeks ago - Genmab A/S Share Capital Reduction - GlobeNewsWire
- 5 weeks ago - Transactions In Connection with Share Buy-back Program - GlobeNewsWire